Atezolizumab

Warning

This publication doesn't include Institute of Computer Science. It includes Faculty of Medicine. Official publication website can be found on muni.cz.

Authors	DEMLOVÁ Regina HEJNOVÁ Renata
Year of publication	2017
Type	Article in Periodical
Magazine / Source	Acta medicinae
MU Faculty or unit	Faculty of Medicine
Citation
Field	Pharmacology and pharmaceutical chemistry
Keywords	Atezolizumab
Description	Immunotherapeutic approaches of anti-tumor therapy based on monoclonal antibodies against control points immune responses are considered to be a breakthrough method in oncology with demonstrable excellent treatment outcomes in a series oncological diagnoses
Related projects:	CZECRIN - Český národní uzel Evropské sítě infrastruktur klinického výzkumu